SMV
Sofinnova Management VIII Portfolio holdings
AUM
$183M
This Quarter Return
+6.21%
1 Year Return
+2.31%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$190M
AUM Growth
+$190M
(+6.7%)
Cap. Flow
-$9.51M
Cap. Flow
% of AUM
-5.01%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
1
Reduced
3
Closed
–
Top Buys
| 1 |
OBSV
ObsEva SA Ordinary Shares
OBSV
|
$39M |
| 2 |
CYTO
Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda)
CYTO
|
$1.84M |
Top Sells
| 1 |
Aclaris Therapeutics
ACRS
|
$22.4M |
| 2 |
ARAV
Aravive, Inc. Common Stock
ARAV
|
$17.1M |
| 3 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$11M |
Sector Composition
| 1 | Healthcare | 80.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Aclaris Therapeutics
ACRS
$209M
| $45.9M | 24.21% | 1,539,480 -750,000 | -33% | -$22.4M |
|
|
OBSV
2
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $39M | 20.59% | +3,749,623 | New | +$39M |
|
|
ONCE
3
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $37.3M | 19.68% | 699,430 -205,556 | -23% | -$11M |
|
|
ARAV
4
DELISTED
Aravive, Inc. Common Stock
ARAV
| $33.4M | 17.6% | 1,563,260 -798,718 | -34% | -$17.1M |
|
5
Natera
NTRA
$23.1B
| $13.8M | 7.25% | 1,550,280 | – | – |
|
|
CYTO
6
DELISTED
Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda)
CYTO
| $7.19M | 3.79% | 7,818,175 +2,000,000 | +34% | +$1.84M |
|
7
Synlogic
SYBX
$17M
| $6.52M | 3.44% | 2,974,812 | – | – |
|
8
Ocugen
OCGN
$319M
| $3.59M | 1.9% | 2,077,040 | – | – |
|
|
INNL
9
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
| $2.36M | 1.24% | 2,103,173 | – | – |
|
|
SPHS
10
DELISTED
Sophiris Bio, Inc.
SPHS
| $566K | 0.3% | 200,000 | – | – |
|